
ACXP P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.43
Average-0.5270
Median-0.5450
Minimum-0.5900
Maximum-0.4300
-0.43
Past Month+0.10 (18.87%)
The P/E ratio for ACXP is -0.43 as of Jun 13, 2025. This represents a decrease of -60.91% compared to its 12-month average P/E ratio of -1.1. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Acurx Pharmaceuticals LLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Acurx Pharmaceuticals LLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Acurx Pharmaceuticals LLC to industry peers.
Acurx Pharmaceuticals LLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Acurx Pharmaceuticals LLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Acurx Pharmaceuticals LLC to industry peers.
ACXP P/E Ratio Insights
See Acurx Pharmaceuticals LLC’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ACXP
Order type
Buy in
Order amount
Est. shares
0 shares
ACXP P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $0.3772 | -0.54 |
May 1, 2025 | $0.4134 | -0.47 |
Apr 1, 2025 | $0.3793 | -0.43 |
Mar 3, 2025 | $0.6703 | -0.61 |
Feb 3, 2025 | $0.7301 | -0.67 |
Jan 2, 2025 | $0.84 | -0.77 |
ACXP End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.43 | -41.89% |
2024 | -0.74 | -79.67% |
2023 | -3.64 | -0.27% |
2022 | -3.65 | +7.04% |
2021 | -3.41 | — |
FAQs About Acurx Pharmaceuticals LLC (ACXP) P/E ratio
The latest P/E ratio of ACXP is -0.43, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Acurx Pharmaceuticals LLC’s last 12-month average P/E ratio is -1.1, compared to its current P/E ratio of -0.43. This reflects a decrease of -60.91%.
Acurx Pharmaceuticals LLC’s current P/E ratio of -0.43 is lower than its last 12-month average P/E of -1.1. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Acurx Pharmaceuticals LLC’s average P/E ratio over the last 3 years is -2.19. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Acurx Pharmaceuticals LLC’s average P/E ratio over the last 5 years is -1.65. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.